Dysequilibrium between caspases and their inhibitors in a mouse model for amyotrophic lateral sclerosis

Eiichi Tokuda1, Shin-ichi Ono, Kumiko Ishige

  • 1Research Unit of Clinical Pharmacy, College of Pharmacy, Nihon University, 7-7-1, Narashinodai, Funabashi, Chiba, 274-8555, Japan.

Brain Research
|April 3, 2007
PubMed

Insights

Mutations in copper/zinc superoxide dismutase (SOD1) trigger apoptosis in familial amyotrophic lateral sclerosis (ALS). Active caspases and suppressed apoptosis inhibitors in the spinal cord indicate early disease involvement and progression.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Familial amyotrophic lateral sclerosis (ALS) is linked to mutations in copper/zinc superoxide dismutase (SOD1).
  • Mutant SOD1 may acquire new toxic properties, causing motor neuron death.
  • Investigating caspase-mediated apoptosis in a rodent model of familial ALS is crucial.

Purpose of the Study:

  • To determine if caspase-mediated apoptosis is associated with the novel cytotoxic properties of mutant SOD1.
  • To analyze the activation of key caspases (caspase-9, -8, -3) and apoptosis-regulating proteins (survivin, XIAP) in the spinal cords of G93A SOD1 transgenic mice.

Main Methods:

  • Utilized a G93A SOD1 transgenic mouse model for familial ALS.
  • Analyzed caspase-9, -8, and -3 protein activity and mRNA levels at early (8 weeks) and advanced (16 weeks) disease stages.
  • Assessed mRNA and protein levels of survivin and X-linked inhibitor of apoptosis protein (XIAP).
  • Compared findings in the spinal cord (disease-affected) versus the cerebellum (unaffected).

Main Results:

  • Active caspase-9, -8, and -3 proteins and upregulated mRNA were found in transgenic mice at 8 weeks, preceding paralysis.
  • Active caspase levels further increased by 16 weeks when paralysis was evident.
  • Survivin levels were suppressed early and increased late, while XIAP levels decreased significantly at 16 weeks.
  • These changes were specific to the spinal cord, not the cerebellum.

Conclusions:

  • Apoptotic processes activated early in the disease play a causal role in ALS pathogenesis.
  • Suppression of XIAP during the advanced stage may contribute to ALS disease expression and progression.
  • Targeting caspase activation and modulating apoptosis inhibitors could be potential therapeutic strategies for ALS.